Clinical Trials Logo

Rectal Cancer clinical trials

View clinical trials related to Rectal Cancer.

Filter by:

NCT ID: NCT02965521 Completed - ColoRectal Cancer Clinical Trials

Survivor Choices for Eating and Drinking - Colorectal Cancer

SUCCEED
Start date: April 10, 2017
Phase: N/A
Study type: Interventional

Epidemiologic data suggest that a Western dietary pattern after diagnosis of colorectal cancer increases risk of disease recurrence and death. High intake of red and processed meat, dairy, refined grains, and sweets/desserts characterize a 'Western dietary pattern'. This study aims to translate the epidemiologic findings into a patient-centered, web-based dietary intervention with text messaging to inform and modify users' dietary choices. The investigators' specific aims are to: 1) Develop a web-based dietary intervention with text messaging for colorectal cancer survivors; and 2) Conduct a 12-week pilot randomized controlled trial to determine the acceptability and feasibility of the dietary intervention among 50 colorectal cancer survivors. All participants will receive standard of care print materials regarding diet following a colorectal cancer diagnosis. Participants in the intervention group will also receive access to a web-based dietary intervention with text messaging for 12 weeks. This study will generate preliminary data on the effect of the intervention on dietary choices among colorectal cancer survivors for future studies.

NCT ID: NCT02935309 Completed - Rectal Cancer Clinical Trials

Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma

Start date: October 14, 2016
Phase: Phase 1
Study type: Interventional

This research study is designed to see if Capecitabine and Lenvatinib in combination with external radiation therapy are effective in treating locally advanced rectal adenocarcinoma in patients who have not yet had surgery, and what the best dosage is.

NCT ID: NCT02864849 Completed - Rectal Cancer Clinical Trials

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Start date: August 2016
Phase: Phase 2
Study type: Interventional

This study is designed to test the efficacy and safety of total neoadjuvant induction and consolidation CapeOX plus neoadjuvant intensity modulated radiotherapy with concurrent capecitabine for MRI defined high-risk rectal cancer.

NCT ID: NCT02860234 Completed - Rectal Cancer Clinical Trials

Tailored Operative or Non-operative Management for Low-risk Rectal Cancer After Intensive Neoadjuvant Treatment

Start date: August 2016
Phase:
Study type: Observational

This study is designed to test the efficacy of tailored operative or non-operative management (NOM) for MRI defined low-risk rectal cancer following neoadjuvant intensity modulated radiotherapy with concurrent capecitabine plus consolidation CapeOX. The main purpose of this study is to increase organ-preservation rate for low-risk rectal cancer patients.

NCT ID: NCT02849717 Completed - Rectal Cancer Clinical Trials

Pre-Habilitation Exercise Intervention

Start date: March 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to see whether exercise can improve the health and well-being of patients scheduled to undergo surgery for a bowel related condition.

NCT ID: NCT02810652 Completed - Pancreatic Cancer Clinical Trials

Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection

Start date: September 2016
Phase: N/A
Study type: Interventional

The purpose of this research study is to addresses the challenge of managing the unique perioperative needs of older cancer patients undergoing surgical resection.

NCT ID: NCT02694718 Completed - Rectal Cancer Clinical Trials

A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer

Start date: March 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the pathological complete tumor response rate.

NCT ID: NCT02665026 Completed - Rectal Cancer Clinical Trials

Effectiveness and Safety Study on Different Timing of Preventive Ileostomy Closure After Surgery for Rectal Cancer

Start date: January 4, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the appropriate timing to do preventive ileostomy closure after total mesorectal excision of rectal cancer. To evaluate the effectiveness and safety of preventive ileostomy closure at different time (12 weeks / 24 weeks after radical resection of rectal carcinoma). This study was expected to demonstrate that the early preventive ileostomy closure after total mesorectal excision of rectal cancer does not increase the risk of complications.

NCT ID: NCT02651701 Completed - Rectal Cancer Clinical Trials

Rectal Cancer Staging Using Whole Body MR-PET

Start date: January 2016
Phase:
Study type: Observational

The purpose of this study is to measure the diagnostic performance of whole body (WB) MR-PET for staging rectal cancer, compared with current standard of care (chest/abdominopelvic CT and rectal MRI) to investigate clinical feasibility of WB MR-PET as a one-stop preoperative imaging modality in patients with rectal cancer.

NCT ID: NCT02641691 Completed - Rectal Cancer Clinical Trials

Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum

NORMAL-R
Start date: May 27, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this research study is to look at how tumors responds to a short course of radiation (5 days) followed by 8 cycles of chemotherapy.